Philips initiated a voluntary recall for some of its sleep apnea machines and ventilators. The American multinational conglomerate company cited concerns for a foam component that may get detached or degrade and become toxic when inhaled by the user.
It was said that if such a thing happens, there is a possibility it could cause health issues including the development of cancer due to toxic and carcinogenic effects. To prevent this and protect the users, Philips issued a recall notification on Monday, June 14.
The affected devices and Philips’ announcement
As per Fox Business, the Philips recall will affect three to four million units of certain machine models that feature Bi-Level Positive Airway Pressure (Bi-Level PAP), Continuous Positive Airway Pressure (CPAC) and the mechanical ventilator machines. It was revealed that the company already issued the first warning over the issue in April.
Philips announced its voluntary recall notification after consulting with regulatory agencies. The company said that with the recalled products, the company will immediately take corrective actions that include the distribution of updated instructions for the repair and replacement of the affected items. As of this time, Philips is continuously monitoring reports of safety issues and so far, it has not received any reports of death due to the product issues.
It was added that due to potential risks of exposure, users may experience headaches, respiratory issues, irritation, inflammation and possible toxic or carcinogenic effects. But fortunately, there is no report of these effects yet related to chemical emissions.
“We deeply regret any concern and inconvenience that patients using the affected devices will experience because of the proactive measures we are announcing today to ensure patient safety,” Philips CEO, Frans van Houten, said in a press release. “In consultation with the relevant regulatory agencies and in close collaboration with our customers and partners, we are working hard towards a resolution. Patient safety is at the heart of everything we do at Philips.”
How Philips will solve the issue
Reuters reported that Philips is now working with the health authorities and regulators for the safety of the consumers. It is looking for a way for the safe replacement of the foam that may potentially become toxic and cause cancer.
It was added that Philips is not conducting tests and it needs to get good results so it can pass the regulatory requirements. The company will also be replacing the products that cannot be repaired or updated.


Qualcomm Stock Surges Despite Weak Guidance After Q2 2026 Earnings Beat
Gold Prices Hold Steady as Iran War and Interest Rate Outlook Weigh on Markets
WTI Crude Oil Prices Rise Amid Iran Conflict Uncertainty
Standard Chartered Q1 Profit Hits Record on Wealth and Investment Banking Growth
Oil Prices Surge Amid U.S.-Iran Tensions and Supply Disruption Fears
Oil Prices Surge Near $120 as U.S.-Iran Tensions Threaten Global Supply
TSMC Exits Arm Holdings with $231 Million Share Sale Amid Strategic Portfolio Shift
Trump Rejects Iran Proposal as Tensions Persist Amid Fragile Ceasefire
Tokyo Inflation Slows Despite Energy Pressures and BOJ Policy Outlook
Asian Stock Markets Rise Amid Wall Street Rally and U.S.-Iran Tensions
Seagate Stock Surges After Strong Q3 Earnings Beat and Bullish Outlook
U.S. Cybersecurity Pushes Faster Patch Deadlines Amid Rising AI-Driven Threats
Why Paycom Was Named a 2026 Platinum Employer on the Where You Work Matters List
Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Meta Raises 2026 Capex Outlook Amid AI Spending Surge, Shares Drop After Earnings 



